Main Page
Deanship
The Dean
Dean's Word
Curriculum Vitae
Contact the Dean
Vision and Mission
Organizational Structure
Vice- Deanship
Vice- Dean
KAU Graduate Studies
Research Services & Courses
Research Services Unit
Important Research for Society
Deanship's Services
FAQs
Research
Staff Directory
Files
Favorite Websites
Deanship Access Map
Graduate Studies Awards
Deanship's Staff
Staff Directory
Files
Researches
Contact us
عربي
English
About
Admission
Academic
Research and Innovations
University Life
E-Services
Search
Deanship of Graduate Studies
Document Details
Document Type
:
Thesis
Document Title
:
Prevalence of Common Thrombophilic Mutations among Sickle Cell Disease Patients in the Western Province of Saudi Arabia
نسبة انتشار أشهر الطفرات الجينية المسببة لتجلط الدم بين مرضى الأنيميا المنجلية في غرب المملكة العربية السعودية
Subject
:
Faculty of Applied Medical Sciences
Document Language
:
Arabic
Abstract
:
Background: Vascular thrombosis is the pathophysiological complications of sickle cell disease (SCD). Inherited thrombophilic mutations may play a role in increasing the risk of thrombosis in sickle cell patients. Factor V Leiden G1691A (FVL), prothrombin G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T are the most common genetic mutations result in thrombophilia and considered as risk factors that may trigger vascular complications. Therefore, this study aimed to investigate the prevalence and clinical impact of factor V Leiden G1691A, MTHFR C677T and prothrombin G20210A mutations among Saudi sickle cell patients. Methods: 90 Saudi sickle cell patients and 90 healthy individuals were recruited. Genotyping of the three thrompophilic mutations was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. Results: The results showed that heterozygous factor V Leiden was found in 29/90 (32.2%) of sickle cell patients and 2/90 (2.2%) in control subjects (p<0.001). Homozygous FVL wasn't seen among patients and control. Heterozygous prothrombin G20210A was present in 18/90 (20.0%) of sickle cell patients compared to 1/90 (1.1%) healthy individuals (p<0.001). Regarding homozygote type of prothrombin G20210A, the prevalence in sickle cell group was 2.2% (p<0.001). Concerning the MTHFR C677T, the prevalence of heterozygote type was 17.8% in the sickle cell group compared to 10% in the control, and regarding homozygote type, the prevalence in sickle cell patients was 1.1% compared to none in control but these differences were not statistically significant. Conclusion: Because of the high prevalence of Factor V Leiden G1691A, prothrombin G20210A and MTHFR C677T among Saudi sickle cell patients, these genetic polymorphisms may act as major risk factors for developing vascular complications in patients with SCD.
Supervisor
:
Dr. Talal Qadah
Thesis Type
:
Master Thesis
Publishing Year
:
1443 AH
2022 AD
Co-Supervisor
:
Dr. Raed Alserehi
Added Date
:
Friday, January 6, 2023
Researchers
Researcher Name (Arabic)
Researcher Name (English)
Researcher Type
Dr Grade
Email
رشــا كـمــال دسـوقـي
Desuqi, Rasha
Researcher
Master
Files
File Name
Type
Description
48801.pdf
pdf
Back To Researches Page